YAP oncogene overexpression supercharges colon cancer proliferation
Open Access
- 15 March 2012
- journal article
- review article
- Published by Taylor & Francis Ltd in Cell Cycle
- Vol. 11 (6), 1090-1096
- https://doi.org/10.4161/cc.11.6.19453
Abstract
The transcriptional co-activator YAP is an evolutionarily conserved regulator of organ size and progenitor cell proliferation. YAP is overexpressed at high frequency in many common human cancers and can directly drive cancer development in mouse models. YAP abundance and nuclear localization are negatively regulated by the Hippo kinase cascade, which, in epithelia, is activated by physiological cell-cell contact. Recent work in intestinal epithelium has established that YAP is constitutively inhibited by the Hippo pathway and entirely dispensable for normal development and homeostasis. YAP serves only in a standby capacity; should cell-cell contact be abrogated, as after intestinal damage, the loss of Hippo input permits increased YAP abundance and nuclear residence. In turn, YAP cooperates with beta-catenin to transactivate genes that promote stem cell expansion for epithelial repair. This interplay between overexpressed YAP and beta-catenin also drives proliferation of colon cancer cells. The dispensability of YAP in normal intestine makes YAP's expression or outputs attractive targets for cancer therapy.NIH [DK17776, CA136567]; Sidney Kimmel Foundation for Cancer Research; Linda J. Verville Cancer Research Foundation; 111 Project of Education of China [B06016]; Fundamental Research Funds for the Central Universities of China [2010111079]; National Natural Science Foundation of China [81101503]; Natural Science Foundation of Fujian [2011J05096Keywords
This publication has 82 references indexed in Scilit:
- Hippo signaling in Drosophila: Recent advances and insightsDevelopmental Dynamics, 2011
- Yap1 Acts Downstream of α-Catenin to Control Epidermal ProliferationCell, 2011
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- Yes‐associated protein is an independent prognostic marker in hepatocellular carcinomaCancer, 2009
- SCALLOPED Interacts with YORKIE, the Nuclear Effector of the Hippo Tumor-Suppressor Pathway in DrosophilaCurrent Biology, 2008
- The TEAD/TEF Family of Transcription Factor Scalloped Mediates Hippo Signaling in Organ Size ControlDevelopmental Cell, 2008
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- Liver regenerationJournal of Cellular Physiology, 2007
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAPCell, 2005